Sterol synthesis is up-regulated in cholesterol-loaded pigeon macrophages during induction of cholesterol efflux

Journal of Lipid Research

Volumn 40, Issue 10, 1999, Pages 1806-1817

  Nordskog, Brian K ^a   Reagan Jr , Jerry W ^a   St Clair, Richard W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cholesterol efflux; Cholesterol synthesis; Foam cells; HMG CoA reductase; Macrophages; Show Racer pigeons; White Carneau pigeons

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL ESTERIFICATION; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; ENZYME ACTIVITY; FOAM CELL; HYDROLYSIS; NONHUMAN; PERITONEUM MACROPHAGE; PIGEON; PRIORITY JOURNAL; REGULATORY MECHANISM;

ACETATES; ANIMALS; APOLIPOPROTEINS A; CARBON RADIOISOTOPES; CELLS, CULTURED; CHOLESTEROL; CHOLESTEROL, DIETARY; COLUMBIDAE; CYCLODEXTRINS; KINETICS; LIPOPROTEINS, VLDL; MACROPHAGES, PERITONEAL; PHOSPHATIDYLCHOLINES; RABBITS; SPECIES SPECIFICITY; STEROLS;

EID: 0032879484     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Clarkson, T. B., R. W. Prichard, M. G. Netsky, and H. B. Lofland. 1959. Atherosclerosis in pigeons: its spontaneous occurrence and resemblance to human atherosclerosis. Arch. Pathol. 68: 143.
2. St. Clair, R. W., H. B. Lolland, and T. B. Clarkson. 1970. Influence of duration of cholesterol feeding on esterification of fatty acids by cell-free preparation of pigeon aorta. Studies on the mechanism of cholesterol esterification. Circ. Res. 27: 213-225.
3. Prichard, R. W., T. B. Clarkson, H. O. Goodman, and H. B. Lofland. 1966. Coronary atherosclerosis. A study of coronary disease occurring naturally in White Carneau pigeons. Arch. Pathol. 81:292-301.
4. Clarkson, T. B., and H. B. Lofland. 1967. Response of pigeon arteries to cholesterol as a function of time. Arch. Pathol. 84: 513-516.
5. Lewis, J. C., R. G. Taylor, and W. G. Jerome. 1985. Foam cell characteristics in coronary arteries and aortas of White Carneau pigeons with moderate hypercholesterolemia. Ann. NY Acad. Sci. 454: 91-100.
6. Lewis, J. C., R. G. Taylor, N. D. Jones, and D. Grimes. 1979. Vascular endothelium in pigeon coronary atherosclerosis. Scan. Electron. Microsc. III: 823-828.
7. Lewis, J. C., R. G. Taylor, N. D. Jones, R. W. St. Clair, and J. F. Cornhill. 1982. Endothelial surface characteristics in pigeon coronary artery atherosclerosis. I. Cellular alterations during the initial stages of dietary cholesterol challenge. Lab. Invest. 46; 123-138.
8. Adelman, S. J., and R. W. St. Clair. 1988. Lipoprotein metabolism by macrophages from atherosclerosis-susceptible White Carneau and resistant Show Racer pigeons. J. Lipid Res. 29: 643-656.
9. Adelman, S. J., and R. W. St. Clair. 1989. β-VLDL metabolism by pigeon macrophages. Evidence for two binding sites with different potentials for promoting cholesterol accumulation. Arteriosclerosis. 9: 673-683.
10. Seo, T., and R. W. St. Clair. 1997. Heparan sulfate proteoglycans mediate internalization and degradation of β-VLDL and promote cholesterol accumulation by pigeon macrophages. J. Lipid Res. 38: 765-779.
11. Brown, M. S., and J. L. Goldstein. 1985. The LDL receptor and HMG-CoA reductase-two membrane molecules that regulate cholesterol homeostasis. Curr. Top. Cell. Regul. 26: 3-15.
12. Brown, M. S., J. L. Goldstein, M. Krieger, Y. K. Ho, and R. G. W. Anderson. 1979. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J. Cell Biol. 82: 597-613.
13. Ho, Y. K., J. R. Faust, D. W. Bilheimer, M. S. Brown, and J. L. Goldstein. 1977. Regulation of cholesterol synthesis by low density lipoprotein in isolated human lymphocytes. Comparison of cells from normal subjects and patients with homozygous familial hypercholesterolemia and abetalipoproteinemia. J. Exp. Med. 145: 1531-1549.
14. Brown, M. S., Y. K. Ho, and J. L. Goldstein. 1980. The cholesteryl ester cycle in macrophage foam cells. J. Biol. Chem. 255: 9344-9352.
15. Ponec, M., J. A. Kempenaar, L. Havekes, J. G. Van der Schroeff, J. J. Emeis, and B. J. Vermeer. 1981. Effects of LDL, HDL and their combination on the endogenous cholesterol synthesis in monocyte-macrophages. Biochim. Biophys. Acta. 666: 405-410.
16. Traber, M. G., V. Defendi, and H. J. Kayden. 1981. Receptor activities for low-density lipoprotein and acetylated low-density lipoprotein in a mouse macrophage cell line (IC21) and in human monocyte-derived macrophages. J. Exp. Med. 154: 1852-1867.
17. Knight, B. L., D. D. Patel, and A. K. Soutar. 1983. The regulation of 3-hydroxy-3-methylglutaryl-CoA reductase activity, cholesterol esterification and the expression of low-density lipoprotein receptors in cultured monocyte-derived macrophages. Biochem. J. 210: 523-532.
18. Knight, B. L., A. K. Soutar, and D. D. Patel. 1987. Non-saturable degradation of LDL by monocyte-derived macrophages leads to a reduction in HMG-CoA reductase activity with little synthesis of cholesteryl esters. Atherosclerosis. 64: 131-138.
19. Angelin, B. 1988. Regulation of 3-hydroxy-3-methyglutaryl-coenzyme A reductase activity in mouse peritoneal macrophages. Biochem. J. 255: 529-534.
20. Warner, G. J., G. Stoudt, M. Bamberger, W. J. Johnson, and G. H. Rothblat. 1995. Cell toxicity induced by inhibition of acyl coenzyme A: cholesterol acyltransferase and accumulation of unesterified cholesterol. J. Biol. Chem. 270: 5772-5778.
21. Edwards, P. A., and J. Ericsson. 1998. Signaling molecules derived from the cholesterol biosynthetic pathway: mechanisms of action and possible roles in human disease. Curr. Opin. Lipidol. 9: 433-440.
22. Randolph, R. K., B. P. Smith, and R. W. St. Clair. 1984. Cholesterol metabolism in pigeon aortic smooth muscle cells lacking a functional low density lipoprotein receptor pathway. J. Lipid Res. 25: 903-912.
23. Phillips, M. C., K. L. Gillotte, M. P. Haynes, W. J. Johnson, S. Lund-Katz, and G. H. Rothblat. 1998. Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes. Atherosclerosis. 137 (Suppl.): S13-S17.
24. Yancey, P. G., and R. W. St. Clair. 1992. Cholesterol efflux is defective in macrophages from atherosclerosis-susceptible White Carneau pigeons relative to resistant Show Racer pigeons. Arterioscler. Thromb. 12: 1291-1304.
25. St. Clair, R. W., R. K. Randolph, M. P. Jokinen, T. B. Clarkson, and H. A. Barakat. 1986. Relationship of plasma lipoproteins and the monocyte-macrophage system to atherosclerosis severity in cholesterol-fed pigeons. Arteriosclerosis. 6: 614-626.
26. Bilheimer, D. W., S. Eisenberg, and R. I. Levy. 1972. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim. Biophys. Acta. 260: 212-221.
27. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
28. Scanu, A. 1966. Forms of human serum high density lipoprotein protein. J. Lipid Res. 7: 295-306.
29. Guertler, L. S., and R. W. St. Clair. 1977. In vitro regulation of cholesterol metabolism by low density lipoproteins in skin fibroblasts from hypo-and hyperresponding squirrel monkeys. Biochim. Biophys. Acta. 487: 458-471.
30. Bernard, D. W., A. Rodriguez, G. H. Rothblat, and J. M. Glick. 1990. Influence of high density lipoprotein on esterified cholesterol stores in macrophages and hematoma cells. Arteriosclerosis. 10: 135-144.
31. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
32. Ishikawa, T. T., J. MacGee, J. A. Morrison, and C. J. Glueck. 1974. Quantitative analysis of cholesterol in 5 to 20 μl of plasma. J. Lipid Res. 15:286-291.
33. Klansek, J. J., P. Yancey, R. W. St. Clair, R. T. Fischer, W. J. Johnson, and J. M. Glick. 1995. Cholesterol quantitation by GLC: artifactual formation of short-chain steryl esters. J. Lipid Res. 36: 2261-2266.
34. Sperry, W. M. 1963. Quantitative isolation of sterols. J. Lipid Res. 4: 221-225.
35. Brown, M. S., S. E. Dana, and J. L. Goldstein. 1973. Regulation of 3-hydroxy-3methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins. Proc. Natl. Acad. Sci. USA. 70: 2162-2166.
36. Guertler, L. S., and R. W. St. Clair. 1980. Low density lipoprotein receptor activity on skin fibroblasts from rhesus monkeys with diet-induced or spontaneous hypercholesterolemia. J. Biol. Chem. 255: 92-99.
37. Rosenfeld, M. E., J. C. Khoo, E. Miller, S. Parthasarathy, W. Palinski, and J. Witztum. 1991. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J. Clin. Invest. 87:90-99.
38. Brown, M. S., and J. L. Goldstein. 1990. Regulation of the mevalonate pathway. Nature. 343: 425-430.
39. Bilheimer, D. W., Y. K. Ho, M. S. Brown, R. G. W. Anderson, and J. L. Goldstein. 1978. Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia. J. Clin. Invest. 61: 678-696.
40. Fogelman, A. M., J. Seager, M. Hokom, and P. A. Edwards. 1979. Separation of and cholesterol synthesis by human lymphocytes and monocytes. J. Lipid Res. 20: 379-388.
41. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
42. Luskey, K. L. 1988. Regulation of cholesterol synthesis: mechanism for control of HMG CoA reductase. In Recent Progress in Hormone Research. J. H. Clark, editor. Academic Press, Inc., San Diego. 35-51.
43. Rudney, H., and S. R. Panini. 1993. Cholesterol biosynthesis. Curr. Opin. Lipidol. 4: 230-237.
44. Cheng, D., C. C. Y. Chang, X. Qu, and T. Y. Chang. 1995. Activation of acyl-coenzyme A:cholesterol acyltransferase by cholesterol or by oxysterol in a cell-free system. J. Biol. Chem. 270: 685-695.
45. Chang, C. C. Y., J. Chen, M. A. Thomas, D. Cheng, V. A. Del Priore, R. S. Newton, M. E. Pape, and T. Y. Chang. 1995. Regulation and immunolocalization of acyl-coenzyme A:cholesterol acyltransferase in mammalian cells as studied with specific antibodies. J. Biol. Chem. 270: 29532-29540.
46. Synouri-Vrettakou, S., and K. A. Mitropoulos. 1983. Acylcoenzyme A:cholesterol acyltransferase. Transfer of cholesterol to its substrate pool and modulation of activity. Eur. J. Biochem. 133: 299-307.
47. Burki, E., J. Logel, and M. Sinensky. 1987. Endogenous sterol synthesis is not required for regulation of 3-hydroxy-3methylglutaryl coenzyme A reductase by low density lipoprotein. J. Lipid Res. 28: 1199-1205.
48. Pinkerton, F. D., A. Izumi, C. M. Anderson, L. R. Miller, A. Kisic, and G. J. Schroepfer, Jr. 1982. 14α-Ethyl-5α-cholest-7-ene-3β,15α-diol, a potent inhibitor of sterol biosynthesis, has two sites of action in cultured mammalian cells. J. Biol. Chem. 257: 1929-1936.
49. St. Clair, R. W., H. B. Lofland, R. W. Prichard, and T. B. Clarkson. 1968. Synthesis of squalene and sterols by isolated segments of human and pigeon arteries. Exp. Mol. Pathol. 8: 201-215.
50. Aviram, M., E. L. Bierman, and J. F. Oram. 1989. High density lipoprotein stimulates sterol translocation between intracellular and plasma membrane pools in human monocyte-derived macrophages. J. Lipid Res. 30: 65-76.
51. Johnson, W. J., R. T. Fischer, M. C. Phillips, and G. H. Rothblat. 1995. Efflux of newly synthesized cholesterol and biosynthetic sterol intermediates from cells. Dependence on acceptor type and on enrichment of cells with cholesterol. J. Biol. Chem. 270: 25037-23046.
52. Phillips, J. P., W. V. Rodrigueza, and W. J. Johnson. 1998. Basis for rapid efflux of biosynthetic desmosterol from cells. J. Lipid Res. 39: 2459-2470.
53. Echevarria, F., R. A. Norton, W. D. Nes, and Y. Lange. 1990. Zymosterol is located in the plasma membrane of cultured human fibroblasts. J. Biol. Chem. 265: 8484-8489.
54. St. Clair, R. W., M. A. Leight, and H. A. Barakat. 1986. Metabolism of low density lipoproteins by pigeon skin fibroblasts and aortic smooth muscle cells. Comparison of cells from atherosclerosis-susceptible and atherosclerosis-resistant pigeons. Arteriosclerosis. 6: 170-177.
55. Naito, M., H. Nomura, T. Esaki, and A. Iguchi. 1997. Characteristics of macrophage-derived foam cells isolated from atherosclerotic lesions of rabbits. Atherosclerosis. 135: 241-247.
56. Atger, V. M., M. de la Llera Moya, G. W. Stoudt, W. V. Rodrigueza, M. C. Phillips, and G. H. Rothblat. 1997. Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J. Clin. Invest. 99: 773-780.
57. Miura, S., T. Chiba, N. Mochizuki, H. Nagura, K. Nemota, I. Tomita, M. Ikeda, and T. Tomita. 1997. Cholesterol-mediated changes in neutral cholesterol esterase activity in macrophages. Arterioscler. Thromb. Vasc. Biol. 17: 3033-3040.
58. Lawler, J. F., Jr., M. Yin, A. M. Diehl, E. Roberts, and S. Chatterjee. 1998. Tumor necrosis factor-α stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J. Biol. Chem. 273: 5053-5059.
59. Phillips, M. C., W. J. Johnson, and G. H. Rothblat. 1987. Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta. 906: 223-276.
60. Libby, P., Y. J. Geng, Y. J. Aikawa, U. Schoenbeck, F. Mach, S. K. Clinton, G. K. Sukhova, and R. T. Lee. 1996. Macrophages and atherosclerotic plaque stability. Curr. Opin. Lipidol. 7: 330-335.
61. Corsini, A., F. Bernini, P. Quarato, E. Donetti, S. Bellosta, R. Fumagalli, R. Paoletti, and V. M. R. Soma. 1996. Non-lipid-regulated effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Cardiology. 87: 458-468.
62. Zhu, B. Q., R. E. Sievers, Y. P. Sun, W. M. Isenberg, and W. W. Parmley. 1992. Effect of lovastatin on suppression and regression of atherosclerosis in lipid-fed rabbits. J. Cardiovasc. Pharmacol. 19: 246-255.
63. Harsch, M., J. H. Braesen, and A. Niendorf. 1997. Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03%) enriched diet for one year. Atherosclerosis. 128: 139-147.
64. Jukema, J. W., A. V. G. Bruschke, A. J. van Boven, J. H. C. Reiber, E. T. Bal, A. H. Zwinderman, H. Jansen, G. J. M. Boenna, F. M. van Rappard, and K. I. Lie. 1995. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The regression growth evaluation statin study (REGRESS). Circulation. 91: 2528-2540.
65. MAAS Investigators, 1994. Effect of simvastatin on coronary atheroma: the multicentre anti-atheroma study (MAAS). Lancet. 344: 633-638.